Chase Investment Counsel’s HealthEquity HQY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,420
Closed -$711K 139
2024
Q4
$711K Buy
7,420
+1,497
+25% +$139K 0.23% 81
2024
Q3
$484K Sell
5,923
-35,063
-86% -$2.71M 0.16% 93
2024
Q2
$3.53M Buy
40,986
+6,572
+19% +$531K 1.25% 29
2024
Q1
$2.81M Buy
+34,414
New +$2.69M 1.05% 39

Other funds holding HQY

Chase Investment Counsel's HQY Position: Q1 2025 in Review

Chase Investment Counsel sold out of HealthEquity (HQY) in Q1 2025, closing a stake of 7,420 shares — an estimated $711K sold.

Chase Investment Counsel first reported a position in HQY in Q1 2024 and held it in 4 quarters. The position peaked at $3.53M in Q2 2024. 464 funds tracked by Wall St. Rank hold HQY as of Q1 2025.

  • Chase Investment Counsel reported no remaining HealthEquity position as of Q1 2025 after selling out during the quarter.
  • Chase Investment Counsel sold 7,420 HealthEquity shares in Q1 2025, an estimated $711K.
  • Chase Investment Counsel first reported a position in HealthEquity in Q1 2024 and held it in 4 quarters.
  • Chase Investment Counsel's HealthEquity position peaked at $3.53M in Q2 2024.
  • 464 funds tracked by Wall St. Rank held HealthEquity as of Q1 2025.

Based on Chase Investment Counsel's 13F filing for Q1 2025, filed 12 May 2025.